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Abstract:   
We estimate a stochastic life-cycle model of endogenous health spending, asset 
accumulation and retirement to investigate the causes behind the increase in health 
spending and longevity in the U.S. over the period 1965-2005. We estimate that 
technological change and the increase in the generosity of health insurance on their own 
may explain 36% of the rise in health spending (technology 30% and insurance 6%), 
while income explains only 4% and other health trends 0.5%. By simultaneously 
occurring over this period, these changes may have led to complementarity effects 
which we find to explain an additional 57% increase in health spending. The estimates 
suggest that the elasticity of health spending with respect to changes in both income and 
insurance is larger with co-occurring improvements in technology. Technological 
change, taking the form of increased health care productivity at an annual rate of 1.3%, 
explains almost all of the rise in life expectancy at age 25 over this period while changes 
in insurance and income together explain less than 10%. Welfare gains are substantial 
and most of the gain appears to be due to technological change. 
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1 Introduction
The growth of health spending is a constant preoccupation of policy makers around the
world. In the United States, real per capita personal health care spending in 2005 was 10
times what it was in 1965 (in constant dollars $5,738 vs. $570). As a fraction of per capita
GDP, health spending in the U.S. has grown from 4% to 16%.
What accounts for this rise? The usual suspects are income growth, the spread of health
insurance and its generosity and, finally, technological progress in health care (Newhouse,
1992). A simple accounting exercise using back-of-the-envelope calculations shows that
income and insurance fall short of explaining the rise and thus that technology must play
a role. Evidence on the long-run income elasticity of health spending suggests that it is
close to 1 (Gerdtham and Jonsson, 2000), and per capita GDP in 2005 was 4 times that of
1965. Hence, income growth would account for at most 40% of the 10-fold increase in health
spending. Similarly, insurance coverage and generosity both expanded over the period. In
1965, consumers paid for 53% of personal health care expenditures, compared to less than
20% in 2005, according to aggregate National Health Expenditure Accounts. The RAND
Health Insurance Experiment suggest a price elasticity of -0.2 to -0.3 for medical spending
(Manning et al., 1987). Hence, insurance growth would explain roughly 12-18% of the
growth in spending. Taken together, income and insurance generated approximately half of
the growth. According to Newhouse (1992), the other half must be due to technology.1
Indeed, technology may also have significantly improved longevity. In 2005, a new-
born male could expect to live 7.3 additional years, according to figures from the Human
Mortality Database (77.7 in 2005, compared to 70.4 in 1965). Most of that rise is due to
lower mortality rates at older ages. There is plenty of evidence that technological innovation
has saved lives. Cutler at al. (2006a) suggest that 70% of the decline in mortality rates can
be attributed to declining mortality from cardio-vascular risk, an area where technological
innovation has drastically changed the way patients are treated. Skinner and Staiger (2009)
1Newhouse (1992) also reviews other explanations such as aging, factor productivity (price) and supply
induced-demand.
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investigate the evolution of survival across hospitals with different levels of technology for
treating heart attacks and show that the largest gains were observed in hospitals where
diffusion of technology, measured by the use of new and more efficient treatments, was the
fastest. Cutler et al. (2006b) argue that technological change is the leading explanation
for the increase in longevity witnessed after 1950. On the other hand, there is skepticism
about the role of income, fueled by empirical evidence that income variation in adult life
at the micro-level does not appear to lead to differences in health outcomes (Adams et al.,
2003; Smith, 2007). The RAND Health Insurance Experiment in the 1970s also showed
that, for the most part, increased insurance coverage did not improve health outcomes in
the non-Medicare population (Manning et al., 1987).
Technological progress may therefore bring about both higher spending and longevity.
But preferences must be consistent with higher spending when technology improves (Hall
and Jones, 2007). New treatments can be more costly than older ones but yield better
health outcomes, in which case health spending will increase if individuals accept to pay the
additional cost. This will depend on preferences. Newer technologies can also be less costly
and more productive than older ones, leading to both cost savings and improved health
outcomes. Still, even less costly technologies might increase spending as a result of two
important effects. First, they may allow new subgroups of patients to be treated effectively,
perhaps as a result of the inability of older treatments to do so, leading to more people
being treated. Cutler and McClellan (2001) argue that treatment expansion is an important
channel through which technological change may have led to more spending. Second, new
treatments for one disease may raise the value of health investments for the population
that does not have the disease due to the complementarity in health investments. For
example, finding a cure for cancer increases the value of health investments for individuals
currently without cancer because it increases their life expectancy, and thus the length of
time over which they can reap benefits from their investments. Murphy and Topel (2006)
argue that this type of complementarity may be important for understanding the social
value of technological progress in health care.
3
Hall and Jones (2007) build a model of the U.S. economy where agents optimally allocate
resources between health and consumption. They show that preferences alone can generate
a rise of the income share devoted to health if the marginal utility of consumption declines
faster than the marginal product of health spending as income rises. But for income alone to
explain the same rise without help from technology, the income elasticity of health spending
must be above 3, which is at odds with empirical evidence. For example, using oil price
shocks to induce variation in income, Acemoglu et al. (forthcoming) find a value of 0.7
in their preferred specification. Gerdtham and Jonsson (2000) review the literature on
international comparisons of health expenditures. Early studies using a cross-section of
countries find income elasticities in the range [1.0, 1.5]. Panel data studies with fixed effects
and dynamic specifications generally report lower elasticies and do not reject a unit elasticity.
Micro studies tend to report much lower income elasticities in the range [0.2, 0.4]. Hence,
other factors such as the expansion of insurance and technological change are needed to
explain the rise without using very large income elasticities.
In this paper, we estimate a life-cycle model where agents make consumption, health
investment, saving and labor-supply decisions in a rich environment that includes uncertainty
and many of the institutions faced by agents over the life-cycle, such as Social Security,
taxation and health insurance. This framework allows us to integrate in a single model the
determinants of both health spending and health/longevity, and to perform counterfactual
simulations that allow for welfare comparisons. We use longitudinal micro data from the
Panel Study of Income Dynamics (PSID) and the Medical Expenditure Panel Study (MEPS)
to estimate parameters of the model. Preference and technology parameter estimates are
then used to perform counterfactual simulations. The estimates imply that health spending
is relatively inelastic to income and price (co-insurance rates), with elasticities of 0.6 and -
0.5, respectively, prior to age 50. We calibrate productivity growth and mortality trends due
to other factors such that we match the 1965 to 2005 experience in terms of health spending
and longevity. The counterfactual simulations show that income, insurance and technology
are complements in explaining the rise of health spending and longevity. The important
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implication of this result is that technology per se is not responsible for the rise in health
spending. Holding constant the economic resources available in 1965, agents would not have
increased by much the share of resources spent on health as a result of new technology
becoming available. Only as resources grew, health insurance coverage expanded, and new
productive treatments were becoming available, did the demand for health care grow as much
as it did. We also investigate the welfare implications of these changes using compensating
variation in expected utility and find that the 2005 economic, health and technological
environment, when compared to the environment in 1965, is worth to agents as much as
76% of their 2005 consumption. Although this estimate may appear to be large, we show
that it is consistent with common estimates of the value of life extension.
A number of recent papers also feature endogeneous health investments. These models
differ in important respects from ours, in particular in formulation, methods employed,
and research questions investigated. Both Halliday, He and Zhang (2009) and DeNardi,
French and Jones (2010) assume survival is exogeneous to health investments. In order to
simultaneously model health spending and survival, our explicitly model endogenizes the
effect of health spending on survival. On the other hand, macro models such as Suen (2005)
are calibrated and focus on representative agents. Instead, we estimate preferences and
technology which allows us to quantify the sources of growth in spending and longevity.
Furthermore, we allow for a rich environment which features detailed Social Security rules
along with a retirement decision. Allowing for retirement may be important as it is another
margin of adjustments for agents (Galama et al., 2013). 2
The rest of the paper is structured as follows. In section 2, we illustrate how income
growth and technology improvements can be complements when it comes to explaining the
rise of health spending. In section 3, we present the richer model, which we estimate in
2Other papers are more distantly related to ours. Blau and Gilleskie (2008) consider a model of retirement
choices where health investments are modeled using doctor visits. They focus on understanding the role
of changes in health insurance on employment of older males. Their model does not include savings nor
endogenous longevity. Yogo (2009) and Hugonnier et al. (forthcoming) consider the problem of portfolio
choice and health spending after retirement. Khwaja (2010) estimates the willingness to pay, or the value
to the individual, of Medicare, developing a model for the demand for health insurance over the life-cycle.
Scholz and Seshadri (2010) estimate a model of retirement and health expenditures and focus on the age
50+ population. They examine the effect of Medicare on patterns of wealth and mortality.
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section 4 on micro-data. In section 5, we perform counterfactual simulations. Section 6
concludes.
2 Stylized Model
To illustrate how different sources of growth interact, we revisit the stylized model in Hall
and Jones (2007). The agent receives a constant annual income y over his life-cycle and
chooses how to allocate his income between consumption and medical expenditures. His
life expectancy, L, depends on how much he spends annually on health, m. The function
relating medical expenditures to the length of life is concave and given by Lz(m), where z
is a technology parameter. The agent derives utility from consumption c, where the utility
function u(c) is concave in c. He faces the budget constraint y = c+m. His lifetime utility is
simply the product of length of life and the utility he gets each year.3 The agent’s problem
is represented by
V (z, y) = max
m
Lz(m)u(y −m)
where V (z, y) represents the maximum lifetime utility that can be attained for a given z
and y. The solution to this problem is a demand for health function, m∗(z, y). The first
order condition is given by
L′z(m
∗)u(y −m∗)− Lz(m∗)u′(y −m∗) = 0.
Define ηL(m) = mL′z(m)/Lz(m) to be the elasticity of the life expectancy function with
respect to health care spending, and ηu(c) = cu′(c)/u(c) to be the elasticity of utility with
3This simple result emerges in a life cycle model with constant income and a rate of return equal to the
subjective time preference rate. Since productivity of medical expenditures does not depend on age and
declines with spending, the consumer will also spend a constant amount on health each year. Hence, the
dynamic formulation simplifies to a static two-goods model with the objective function being the product
of per-period utility times longevity (Hall and Jones, 2007).
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respect to consumption. The first-order condition can be re-written as
m∗ =
ηL(m
∗)
ηu(m∗)
1 + ηL(m
∗)
ηu(m∗)
y.
Note that m
∗
y is monotonically increasing in
ηL(m
∗)
ηu(m∗) . If the longevity and utility functions
are both of the constant elasticity form, a constant share of income is spent on health. Hence,
medical expenditures do not grow faster than income as income rises.
Hall and Jones (2007) note that if utility is given by u(c) = b+ c
1−σ
1−σ where b is positive,
then the elasticity of utility will not be constant. In fact, assuming a risk aversion parameter
σ > 1 yields a declining elasticity of utility when consumption rises. For a constant elasticity
of the longevity function, this implies a rising share of income is spent on health as income
rises.
Technology can also induce a rising share of income devoted to medical expenditures.
Consider a simple functional semi-log specification for the production function. This provides
a good approximation since life expectancy has increased linearly by roughly 2 years every
10 years and the rate of growth of health spending has been relatively constant, Lz(m) =
Lmin + z log(m), where m ≥ 1, and Lmin is the minimal longevity one can achieve without
spending on health (defined as mmin = 1, for convenience of exposition). The elasticity of
the longevity function is given by ηL(m) = z/Lz(m), which increases with z but decreases
with m. Because the longevity function Lz(m) is bounded from below (Lz(mmin) = Lmin),
technology as captured by z, increases the elasticity of health spending. If technological
progress z increases sufficiently fast so that it outweighs the competing effect of increasing
health spending m, an increasing share of resources is spent on health.4
The simple model illustrates that the optimal solution for the allocation of resources
is not separable in terms of income and productivity. But it is not immediately obvious
that the model suggests a role for complementarity. Hence, we resort to a simple numerical
exercice. According to the Human Mortality Database (HMD), period life expectancy at
4This would not be true if Lmin = 0 in which case ηL(m) = 1/ log(m).
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birth has risen from 70.4 to 77.7 years from 1965 to 2005. Using National Health Expenditure
Accounts (NHEA) data, average personal health spending was $570 in 1965 (in 2005 dollars,
inflated using CPI) while it was $5,738 in 2005. We calibrate parameter values to match
the rise in longevity and health spending.5
With 1965 technology we can solve for optimal medical expenditures given income in
2005. This tells us by how much medical expenditures would have risen keeping technology
constant. Medical expenditures would have increased by $3,108, or about two thirds of the
observed increase. The income elasticity of medical expenditures is therefore 1.69 using the
1965 technology. In a second counterfactual, we keep income constant at its 1965 level and
bring the technology to its 2005 level. Optimal medical expenditures increase by a mere $354:
technology does not appear to play a role in increasing health spending. More importantly,
the sum of those two independent effects is $3,461, which falls short of the observed (and
predicted) $5,168 increase in medical expenditures over the period. The unexplained portion
is a complementarity effect. An additional $1,860 increase in health spending, representing
36% of the total, arises from both technology and income improving concurrently. Optimal
medical spending is more sensitive to income with a more productive technology. Improved
technology alone is not enough to explain the growth in health spending; preferences must
also yield an increased demand for health.
This illustrative and simplified example shows that complementarity effects between
technology and income may be important. But the static model may not be sufficiently
realistic. For example medical expenditures are not constant over the life-cycle. They
increase rapidly toward the end of life. The static model may also not be best suited to study
other factors, such as the expansion of health insurance, which has changed the marginal
cost of spending on health. The marginal cost also varies over the life-cycle (for example
5We use somewhat arbitrary numbers to calibrate Lmin. We take the 1950 life expectancy, 68 years, as
an estimate of Lmin in 1965. We assume that 50% of the rise in longevity is due to factors other than health
spending (Hall and Jones assume 40%) which yields Lmin in 2005 of 71.7 years. Using these numbers we
can solve for z in 1965 and 2005, which yields 0.38 in 1965 and 0.70 in 2005. The annual rate of growth in
the technology parameter z is thus 1.5%. Using the two instances of the first-order condition above (1965
and 2005), income per capita in each period, we can solve for the preference parameters consistent with the
observed growth in medical expenditures. Per capita income in 1965 is $11,704 while it is $42,482 in 2005
(all 2005 dollars) according to Penn World Tables. We obtain b = 0.228 and σ = 1.424.
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due to Medicare), as do mortality risks and income. There might also be other benefits to
investing in health, such as the ability to enjoy leisure (which may not be the case when
one is sick). Income may depend on health through labor supply, which is not modeled
in the stylized model. Finally, since the strength of complementarity effects will depend
on both technology and preference parameters, we may want to estimate these parameters
from micro-data. Hence, we construct - and subsequently estimate on micro-data - a more
sophisticated model that includes many realistic features of the decision environment faced
by agents. This more sophisticated model allows one to assess simultaneously the effect of
each factor on health spending and longevity, and examine welfare effects.
3 Model
3.1 Environment
Consider a household head who starts his life-cycle at age t = 25. He has wealth, wt, and
health status, ht, the latter taking three possible values corresponding to the self-reported
health status scale we will use {1 = poor or fair, 2 = good, 3 = very good or excellent}.
Initial wealth and health status are given by w25 and h25. He has a main job, with health
insurance, ft, taking three possible values {1 = no coverage, 2 = employer-tied coverage, 3
= retiree coverage} and earnings, ye1.
The agent chooses consumption, ct, and medical expenditures, mt, at each age. His
earnings, yet , are stochastic. Starting at age 50, the agent can choose to quit work (pt = 1
if working, pt = 0 if not). But this decision is not irreversible. He can elect to return to
work. At age 62, he becomes eligible for Social Security benefits, ysst , which he may claim
or not, sst (sst = 1 if benefits are claimed, zero if not). At age 65, he becomes eligible for
Medicare. After age 70, there is no work nor claiming decision.
Health follows a persistent stochastic process, which depends on age, current health, and
medical expenditures. Medical expenditures are incurred voluntarily and improve health.
This improvement process has two benefits. First, it increases the amount of time available
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for leisure and work (by reducing time being sick) and thereby increases the quality of life
in future periods. Second, it lengthens life. Longevity is endogenous in the model. But
there is a practical limit on human life, set at age 110.6 If the agent has insurance, medical
expenditures are partially paid for by an insurer, either non-governmental (employer-tied or
retiree) or governmental (Medicaid or Medicare). Agents with employer-tied coverage loose
coverage if they quit before the age of Medicare eligibility. We follow French and Jones
(2011) who assume that the employer does not offer insurance if the agent returns to work
at a later date. This is not the case for jobs with retiree insurance coverage. Those workers
retain coverage even if they quit their job. Finally, if resources are sufficiently low, the agent
may qualify for Medicaid.
3.2 Preferences
The agent derives utility from consumption and leisure. The amount of leisure time available
depends on whether the agent works and on his health status. We specify the following utility
function
u(ct, ht, pt) = αh +
(cγt (L− ςppt − φh)(1−γ))(1−σ)
(1− σ)
where L is the maximum annual amount of leisure available (set to 4000 hours), and ςp =
2000 is the number of hours worked when working full-time. The parameter αh is the
baseline utility level in health state ht which governs the utility benefit of living longer. We
set α1 = 0. Leisure time depends on health through a leisure penalty, φh, with φ3 = 0
imposed as a normalization (L thus represents the maximum amount of leisure available
in very good / excellent health). The agent’s discount factor is β, the coefficient of risk
aversion is σ, and γ governs how much consumption is valued relative to leisure. Denote the
preference parameters to be estimated by the vector θ = (α2, α3, γ, φ1, φ2, σ, β).
6The maximum age is set at 110 for computational reasons. Solutions to the model are insensitive to this
choice for higher maximum ages.
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3.3 Resources
The agent has four potential sources of income. First, the agent has earnings if he works,
yet . Second, the agent has other income which includes spousal earnings as well as private
pension income (annuities, etc), yot . Third, the agent can collect social security benefits,
ysst , if eligible. Finally, he earns interest income on his non-pension wealth, rwt, where r is
the real rate of return and wt is current wealth. Total net income is given by
yt = τn(y
e
t , y
o
t , y
ss
t , rwt)
The net income function, τn, takes account of Federal taxes as well as Social Security and
Medicare contributions (see Appendix A for details). The real rate of return is set at 4%.
Resources available for spending (on either consumption or medical expenditures) are
given by
xt = wt + yt
If those resources fall below a floor, xmin, government transfers are provided. The formula
for transfers is given by
trt = max(0, xmin − xt)
Out-of-pocket medical expenditures are given by
oopt = ψ(ft, t, trt)mt
where the co-insurance rate, ψ, depends on insurance coverage, age and transfer receipt.
Prior to age 65, the agent who does not have insurance and receives transfers is assumed to
be on Medicaid. He faces a lower co-insurance rate than without insurance.
The resource constraint is completed with the equation for wealth accumulation. Agents
cannot end the period with negative private wealth. Hence, there is a borrowing constraint.
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Wealth at the end of the period is given by
wt+1 = xt + trt − ct − oopt
The earnings process is quadratic in age and features an AR(1) error structure:
log yet = pi0 + pi1t+ pi2t
2 + ηt
where the earnings shock is given by ηt = ρηt−1 + εt, εt ∼ N(0, σ2ε).7
Other income, yot , which includes spousal earnings and private pension income, is also
quadratic in age and depends on the sum of earnings and Social Security income of the
agent head. This is done to preserve the correlation between own and other income at the
household level. Because cohort effects will be present in the data and institutions differ
across cohorts, the model will be constructed for an agent born in 1940. That agent was 25
in 1965. We do not model changes in the tax, insurance and Social Security systems over
time. Instead, we assume the 1990 environment prevails. In the model, this corresponds to
the agent being age 50, when he starts making labor supply decisions. The Social Security
system he faces was shaped almost entirely by the 1983 Social Security reform.8
The earnings base for computing Social Security income is the average indexed monthly
earnings (AME), amet, which takes the average of the highest 35 years of earnings. Details
on the modeling of Social Security and the application process is found in Appendix A.
7In principle, earnings could depend on health status. However that effect likely occurs through hours
worked rather than wages (Currie and Madrian, 1997). Since workers choose labor supply beyond age 50,
(lifetime and current) earnings will effectively depend on health.
8An alternative would be to build on changes over time in tax and pension rules. Assuming these were
anticipated by our agents would not create a drastically different world than what is assumed here since
the important decisions agents make occur after age 50 and thus agents would anticipate the same Social
Security and tax system we use. Of course, changes to taxes are likely unanticipated but this is harder to
build into the model as it would require to model expectations. Our approach of a fixed tax and Social
Security system is similar to that followed by a number of authors (e.g., French, 2005 or DeNardi, French
and Jones, 2010).
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3.4 Health Process
Health follows a dynamic process that depends on current health, ht = k (k = 1, 2, 3), age,
t, and medical expenditures, mt . We specify the following dynamic multinomial model
Pr(ht+1 = j|ht = k, t,mt) = e
δ0jk+δ1jt+δ2j logmt+δ3j logm
2
t∑
j′ e
δ0j′k+δ1j′ t+δ2j′ logmt+δ3j′ logm2t
.
where j = 1 is the base category (fair or poor health). The productivity of medical expen-
ditures will thus depend on the parameters {δ2,j , δ3,j}j=2,3. Health is persistent, which is
captured by the parameters, δ0,jk, and it depreciates with age, δ1,j . This health production
function is consistent with the view that health is a stock which depreciates over time and
can be replenished by investments (Grossman, 1972). The dependence on medical expen-
ditures is flexible and in particular allows for a concave relationship between health and
medical expenditures.
The likelihood of death depends on age and health and follows a Gompertz hazard
function such that
Pdh,t = Pr(dt+1 = 1|ht+1 = k, t) = 1− e−e
δ6te
δ7,k
.
Thus mortality depends indirectly on medical expenditures through their effect on health
status.
3.5 Maximization Problem
Denote the state space at age t as st = (ht, ηt, sst, ft, amet, wt). The agent’s maximization
problem can be written as a Bellman equation
Vt(st) = max
ct,mt,pt,sst+1
u(ct, ht, pt) + β
∑
h
(1− pdh,t)ph,tEηt+1Vt+1(st+1)
where pdh,t is the mortality probability given health and age, and ph,t is the probability of
transition to state ht given age, current health and medical expenditures. The term Eηt+1
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is the expectation operator with respect to the distribution of earnings shocks given current
earnings. This optimization problem is subject to the law of motion for wt, amet, constraints
on the transitions of other state variables, and constraints on the choice set. We proceed
by recursion to solve for optimal decision rules. Details on the solution method are given in
Appendix E.
4 Data and Estimation
We focus on males as their labor supply behavior is more likely to be consistent with the
model (i.e., working full-time prior to age 50 with no interruptions). We use two main
longitudinal datasets to estimate auxiliary processes and parameters of the model. First,
we use the Panel Study of Income Dynamics (PSID) for data on income, wealth and work.
We use the 1984 to 1997 waves as well as the wealth surveys of 1984 to 2005 (7 waves).
Details on sample selection and the construction of the variables used in the PSID are given
in Appendix B.
The PSID has data on health but not on total medical expenditures of the agent. Fur-
thermore, mortality follow-up in the public version of the data is incomplete and leads to
low mortality rates (French, 2005). Instead, we use the Medical Expenditure Panel Survey
(MEPS) to estimate the health process. Members of the panel are initially drawn from Na-
tional Health Interview Survey (NHIS) respondents and remain in the panel for two years.
Self-reported health is measured on a 5-point scale (poor, fair, good, very good, excellent);
we group these in 3 categories to save on the dimension of the state-space {poor or fair,
good, very good or excellent}. The MEPS dataset is also used to estimate the co-insurance
function, ψ(). Details on sample selection and the construction of variables used in MEPS
are given in Appendix B.9
Following recent papers estimating life-cycle models similar to the one presented here
9Both PSID and MEPS (public version), despite having information on insurance, lack information on
retiree health insurance coverage. The model assumes this coverage is constant prior to retirement. We use
the Health and Retirement Study (HRS) to compute retiree health insurance coverage rates for those born
between 1935 and 1945 when they were age 50 to 55.
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(e.g. French, 2005), we use a two-step estimation strategy to estimate the parameters of
the model. We first estimate auxiliary processes (earnings, health, etc.) and then estimate
preferences using the method of simulated moments.
4.1 Auxiliary Processes
4.1.1 Resources
The earnings and “other income” processes are estimated using PSID data. Parameters of
the earnings process are estimated by fixed effects regression. The AR(1) term is estimated
from the residuals of the process using minimum distance techniques. Earnings are hump-
shaped and peak around age 49 years old. The estimate of the autocorrelation coefficient
ρ is 0.978 and the variance of the innovation is σ2ε = 0.008 (see Appendix C for details on
the estimation). The “other income” process is estimated by instrumental variables using
education as an instrument (French, 2005). “Other income” is also hump-shaped, with a
peak at age 51. The coefficient of earnings and Social Security benefits of the agent head pi4
is 0.306. We report more details in Appendix C.
4.1.2 Health and Mortality
We need to address the potential endogeneity of medical expenditures when estimating the
health process. Indeed, medical expenditures may depend on the incidence of a health
shock between waves. On the other hand, unobserved heterogeneity is unlikely to be a large
source of bias as the health process controls for current health. To minimize this risk, we
also add controls for risk factors when estimating the production function (smoking and
obesity). In this context, a valid instrument is one that 1) predicts medical spending 2) but
is uncorrelated with the incidence of a health shock given current health and risk factors.
We choose current (log) income. Due to the persistence of income, it predicts future income
and thus future medical spending as found in studies looking at the effect of income on
spending. However, it is unlikely to be correlated with the incidence of a health shock
given current health and risk factors. As detailed in Appendix D, we use a control function
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approach (Peltrin and Train, 2010). We first estimate an equation for the log of medical
expenditures given current health, risk factors and the log of current income. The estimated
income elasticity is 0.124 and is highly statistically significant (partial F=26.7). A measure
of the unobservables that may be correlated with future health is the residual from that
regression, which we then plug into the health process. We estimate the multinomial logit
by maximum likelihood. We account for first-step estimation noise by bootstrapping the
entire procedure to compute standard errors. The estimated effects reveal moderate positive
effects of medical expenditures on health and the relationship is concave. A 50% increase
in medical expenditures increases the probability of being in excellent health in the next
period by 6.5 percentage points at $5,000 of spending (22% are in excellent health in the
estimation sample). Estimation results are reported in Appendix D.
Not surprisingly, the maximum likelihood estimates of the mortality process reveal that
better health is associated with lower mortality risk. Combining the mortality and health
process estimates, we estimate the effect of medical expenditures on mortality risk. Figure 1
shows the resulting mortality rates by medical spending level and current health status for
individuals age 65+. Mortality falls with increased spending, but the effect diminishes as the
level of spending increases. The first dollars of medical expenditures are more productive in
almost all states, in particular in good health.
4.1.3 Other Institutional Parameters
The resource floor is set at $10, 000. The real rate of return is set at 0.04. We construct
co-insurance rates, ψ(), using MEPS data. We take the ratio of out-of-pocket medical
expenditures to total medical expenditures as our estimate of the co-insurance rate (see
French and Jones, 2011, for a similar methodology). This yields a median co-insurance
rate of 25% for individuals with tied-employer insurance, 7% for those receiving government
transfers (i.e. those on Medicaid), 100% for those without insurance and ineligible for
Medicaid and 20% for those on Medicare. Appendix A provides details on the construction
of these shares and the rationale behind other numbers.
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4.2 Preference Parameters
The remaining parameters to estimate are θ = (α2, α3, γ, φ1, φ2, σ, β). We estimate these
parameters by the method of simulated moments (MSM) (Gourinchas and Parker, 2002;
French, 2005). This is done by matching moments from the data with moments obtained
from simulations of the model. The moments chosen are: average wealth over 5-year intervals
between ages 35 and 70; average medical expenditures over 5-year intervals between ages 35
and 85; proportion of individuals working, by health status, at 2-year intervals between ages
56 and 68; and finally, mortality rates over 5-year intervals between ages 50 and 95. These
profiles are constructed using the methodology outlined in French (2005) and accounting for
cohort and family composition effects. Appendix E gives details on the construction of each
profile.
The wealth profile primarily provides information on σ and β following the usual iden-
tification arguments. The labor force participation moments by health status provide in-
formation on γ, φ1 and φ2, keeping σ and β constant. Assuming (σ, β) are determined by
previous information, the medical expenditures profile helps determining (α2, α3) given that
the health process is estimated in the first step. We have 50 moments for 7 parameters.
The overidentification test statistic therefore has a χ250−7 distribution. More details on the
properties of the estimator are found in Appendix E. 10
4.2.1 Estimation Results
Table 1 reports parameter estimates along with standard errors. We obtain an estimate for
the general curvature of the utility function, σ̂ = 3.365 (se = 0.958). Given our estimate
of the consumption share in the utility function, γ̂ = 0.436 (se = 0.005), we obtain the
coefficient of risk aversion, keeping labor supply fixed, as −(γ̂(1 − σ̂) − 1) = 2.03 (French,
10Since the baseline utility levels are quite sensitive to the choice of other parameters, we rescale as
α∗h = −αh (x
γ
minL
1−γ)(1−σ)
(1− σ) , h = 2, 3
Hence, the estimates of α2 and α3 should be interpreted in units of baseline utility measured at xmin and
maximum leisure.
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2005). Hence, our estimate of the coefficient of relative risk aversion is close to estimates
reported in the literature, and very close to the estimate of 2 used by Hall and Jones
(2007). We estimate that agents are patient, with a discount factor estimate of β̂ = 0.984
(se = 0.036). This estimate is slightly lower than the parameter estimate of 0.992 used
in Hall and Jones (2007). These parameters are statistically significant at the 1% level.
The estimates of the amount of leisure time lost when in poorer health are φ̂2 = 371.6
(se = 442.3) and φ̂1 = 696.1 (se = 708.3), representing 9.2% and 17.4% of maximum leisure
time available. However, these parameter estimates are imprecise and we cannot reject a
value of zero. Part of the reason for the imprecision may have to do with the fact that we
only model labor force participation and not hours worked. Finally, estimates of α1 and
α2 are respectively 0.190 (se = 0.149) and 0.229 (se = 0.047), with only the latter being
statistically different from zero. Overall, utility increases with health, which has an impact
on the desire of agents to invest in health.
4.2.2 Model Fit
The model fits the data well given that we only have 7 preference parameters and none of
these parameters depend on age. The overidentifying restriction test statistic takes a value
of 164.8. Formally, the restrictions are rejected (p-value < 0.01). However, inspection of
the simulated profiles in Figure 2 shows a relatively close fit. The simulated moments are
for the most part within the confidence intervals of the moments estimated from the data.
There are three exceptions. First, we predict a decline in wealth after age 65 which we could
not detect in the data. One possible explanation is that we did not incorporate bequests in
the model (French, 2005). The second exception is labor force participation of individuals
in poor health at ages 56 and 58. We over-predict labor force participation at those ages
for this group. Two explanations appear plausible. The first is that we did not model
disability insurance, which provides another exit route to retirement for individuals in poor
health. The other is that we did not model private defined-benefit pensions, which may
provide an incentive to stop work early. Despite the fact that we did not allow any of the
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preference parameters to depend on health, the model is able to capture the overall patterns
of declining labor force participation without any direct dependence of utility on age. The
third exception is that we over-predict mortality at advanced ages while under-predicting
it at younger ages. However, as we show below the life expectancy estimates implied by
the model are roughly consistent with what we observe from mortality data (78.1 years old
compared to 77.7). These minor deviations are unlikely to lead to very different simulation
results for the scenarios we investigate below.
4.2.3 Income and Insurance Elasticities
Since the response of medical spending to income and co-insurance rate variation is central
to the questions we asked, it is worth investigating the elasticities that the model generates.
To do this, we use simulated data generated by the model. We focus on individuals younger
than 50 since their labor supply is fixed and, thus, income and co-insurance variation is
exogenous, conditional on initial conditions. We perform regression analysis of log spending
on the log of the co-insurance rate. The coefficient on log income can be interpreted as an
elasticity. We control for age fixed effects. In some specifications, we control for current
health and assets. Finally, we also estimate a fixed effects regression. Estimates of the
income and co-payment elasticities obtained by regression are reported in Table 2.
The income elasticities range from 0.513 to 0.592. These elasticities fall between macro
(closer to 1) and micro (0.2-0.4) estimates of the income elasticity of health spending. Esti-
mates are closer to those obtained by Acemoglu et al. (forthcoming). They report a central
estimate of 0.7. Hall and Jones (2007) obtain much higher elasticies (higher than 2) as they
are able to explain the rise in the fraction of income devoted to health only as a result of
income growth. Our model estimates will not lead to a rising share of income devoted to
health as income rises.
As for the co-pay elasticity, we obtain regression estimates of -0.555 without controls and
-0.570 with controls. This is larger in magnitude than estimates from the RAND Health
Insurance Experiment, which are closer to -0.2 (Manning et al., 1987). There are a number
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of reasons why we obtain larger elasticities. First, we do not impose a stop-loss on health
spending. The RAND Health Insurance Experiment varied co-insurance rates exogeneously
in an environment where out-of-pocket expenditures were subject to a limit (Manning et
al., 1987). Second, our “random” assignment of insurance status is permanent until age 65
(or until retirement). The assignment of co-insurance rates was limited to a few years in
the RAND Health Insurance Experiment. This could explain why our elasticity estimate is
larger.
We can also investigate how health spending varies by insurance status near age 65. In
Figure 3, we report average simulated total medical expenditures by age and initial insurance
status (hence insurance status does not vary for each individual over the period). We see
that for those with retiree coverage, there is little jump in medical expenditures at age 65.
There is a small increase in spending for those with employer-tied coverage, from $7,253.8
to $8,028.8. This is due to the fact that a fraction of those with employer-tied coverage quit
work and hence lose health insurance coverage. The greatest change in medical expenditures
at age 65 is found for the uninsured, who spend $3,548.9 on average at age 64 compared to
$8,529.6 at age 65. This jump represents an increase of 140% in health spending or a co-pay
elasticity (using the effective change in co-pay) of 1.83. Interestingly, there is evidence of
intertemporal substitution as medical spending at age 65 is actually higher for the previously
uninsured than for those with continued coverage ($8,529.6 vs. $7,488.6). This is consistent
with evidence from Card et al. (2008) who find that health care use appears to increase
discontinuously at age 65 for those more likely to lack health insurance coverage prior to
age 65.
5 Counterfactual Simulations
With the estimates of preferences and technology obtained in section 4, we simulate the ex-
perience of a particular cohort under various counterfactual scenarios. We ask the question:
how would the 1940 cohort, which was 25 years old in 1965, have fared had changes affect-
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ing financial resources, insurance coverage, technology and risk factors not taken place? To
answer this question, we look back at some of the important factors that may have changed
over the period up to 2005 and that may have affected both health spending and longevity.
We roll those factors back to 1965 levels, which we call the 1965 environment. We then
successively introduce those changes and evaluate their effect.
5.1 The 1965 compared to the 2005 environment
Changes between 1965 and 2005 can broadly be grouped into four areas of change: financial
resources, the generosity of health insurance, technology, and “other” factors.
Financial resources: The income available for consumption and health spending has
increased over the years. As in Hall and Jones (2007) we use growth in real per capita GNP,
which averaged 2% annually over this period. Affecting after-tax income, taxes were higher
in 1965. Gouveia and Strauss (2000) compute average tax rates by income from 1966 to
1989. We use the 1966 tax function instead of the 1989 tax function in our 1965 environment.
Finally, the generosity of Social Security benefits has increased over time, primarily due to
two effects. First, generosity has increased due to changes in the computation of the primary
insurance amount (PIA), which went from replacing 30% to 40% of the ame. Second, the
1983 Social Security reform expanded the delayed retirement credit to 7% for those born in
1940. We eliminate this credit in the 1965 environment.
The generosity of health insurance: After the introduction of Medicare, three key
changes have increased the generosity of health insurance in the United States. First, there
has been a decline in the uninsured among the non-Medicare population, from 26% in 1962
to 20% in 2005. Second, there has been an expansion of the generosity of employer provided
health insurance. We calculate that co-payments decreased from an average of 60% in
1965 to 20% in 2005. Third, changes in Medicare coverage have increased the generosity of
benefits. A few years after Medicare’s 1965 introduction, out-of-pocket expenditures were
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equal to 30% of the program’s total spending. In 2005, they represented 20% of total outlays
according to our calculations.
There are two other sets of factors that may have affected both health and spending: tech-
nology and “other factors”. Both are hard to measure from outside sources. Hence, we review
the relevant evidence and resort to a calibration exercice.
Technology: Cutler and McClellan (2001) give various examples of important changes in
productivity that may have improved survival with overall positive benefits. They point
to a 1.5% annual decline in the quality-adjusted price of treating heart attacks as a mea-
sure of technological progress. Similarly, Skinner and Staiger (2009) show that in treating
heart attacks there is roughly a 3 percentage point difference in survival between hospitals
with rapid diffusion of new treatments and those with low diffusion. Improvements in risk
adjusted survival average 0.5% year over the period 1985-2004. 11
Other factors: At the same time, other factors have likely affected the health of this
cohort. The first obvious candidate is smoking, which has large impacts on mortality. The
relevant measure for understanding its effect on life expectancy is the lifetime exposure of a
given cohort rather than point-in-time prevalence of smoking (Preston, Glei and Wilmoth,
2011). The former increased until the mid 1980s while the latter declined over the period.
Estimates of mortality that can be attributed to smoking range from 10% in 1965 to 24%
at peak lifetime exposure in 1985. Preston, Glei and Wilmoth (2011) estimate that life
expectancy among men at age 50 would have been 0.9 years higher in 2002 if the increase
in lifetime smoking had not taken place. Another key factor is the increased prevalence of
obesity, starting in the mid 1970s. Ruhm (2007) uses NHANES data from 1961-62 to 2004
to estimate comparable obesity rates for males and females, using measured rather than
self-reported weight and height. For males, obesity rose from 13.4% to 31.5%, or roughly
11Medical prices, as measured by the medical CPI, have increased at a rate close to 2% per year. However,
as discussed in Berndt et al. (2001), this increase in prices likely reflects changes in type and quality of
procedures. In this paper, we make the assumption that medical prices, relative to consumption goods,
remain constant between 1965 and 2005.
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2.1% per year. Both these factors tend to support the view that factors other than financial
resources, health insurance and technology may have had an effect on survival rates over the
period 1965-2005 - in this case, a negative one. On the positive side, improvements in air
pollution may have lead to an independent reduction in mortality rates. One study argues
that as much as 15% of the increase in life expectancy in 51 major U.S. cities during the
80s and 90s may be attributed to improvements in air quality (Pope et al., 2009). Hence,
it is unclear whether these “other factors” in aggregate had a net positive or negative effect
on mortality rates over the period.
We model technology and “other” factors in terms of changes in two parameters of the
model. Technological change is modeled as a change in the productivity parameters of the
production function δ2,j (see section 3.4). Let κ1 be the rate of growth in productivity. Thus,
δ19652,j = e
−κ140δ2,j . We define the annual rate of growth of mortality due to “other factors”
as κ2. Hence, we have two unknown parameters (κ1, κ2). We use a calibration procedure
to find the value of these parameters. We consider an environment with financial resources
and insurance as they were in 1965. Let the simulated average medical expenditures in
that scenario with values κ1 and κ2 be defined as m˜1965(κ1, κ2). Similarly, simulated life
expectancy is given by e˜1965(κ1, κ2). The actual 1965 values are obtained from National
Health Expenditure Accounts and period life-tables for 1965, m1965 = 569.8 and e1965 =
70.01. We solve for the values of κ1 and κ2 such that we match these values. Relative to
2005, an increase in κ1 tends to lower both health spending and longevity in 1965 while
an increase in κ2 increases longevity while decreasing health spending. The values which
solve this system of two equations are κ̂1 = 0.013 and κ̂2 = −0.009. Hence, these estimates
suggest that negative factors such as the increase in lifetime prevalence of smoking in the
first part of the period and the prevalence of obesity outweighed positive factors such as
improvements in air quality, and that productivity in health care improved at a pace of
1.3% per year.
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5.2 Contributions to Historical Growth in Spending and Longevity
We now perform the following counterfactual experiment. Imagine that starting from 1965,
we introduce each of the changes separately and look at health spending and longevity.
We can then compute the contribution of each factor to the growth of health spending
and longevity observed over the period. As we show in section 2, there is the potential
for complementarity effects. Hence, the residual growth unexplained by the sum of each
contributing factor reflects such effects.
In Table 3, we report the results of the simulations in terms of total medical expenditures,
out-of-pocket medical expenditures and life expectancy. We also report as the last outcome
a welfare measure based on the comparison of average expected utility at age 25 in each
scenario. For scenarios where expected utility is larger than in the 1965 environment, we
estimate the fraction of annual consumption in the 2005 environment which would have
to be taken away for this average individual to be as well off as in the 1965 environment.
Hence, it is a measure of compensating variation (CV).
When letting income grow at 2% per year from the 1965 baseline and implementing
tax and Social Security changes, health expenditures increase to $771.7 from $569.1 at the
baseline, a 34% increase. The income elasticity is thus 0.29 in the 1965 environment. This
suggests that the income elasticity has increased over time since our estimate in the 2005
environment was closer to 0.55 (Table 2). Life expectancy only increases by half a year due
to income growth alone. Because the share of income devoted to health care does not rise
(it decreases), consumption expenditures increase. This leads to a substantial welfare gain,
representing 26.7% of average consumption expenditures in the 2005 environment.
Improvements in insurance from the 1965 baseline do not increase medical expenditures
by a much larger amount. With 2005 insurance parameters, average medical expenditures
increase to $929.2, a 63% increase. Longevity increases by 0.3 years due to the expansion of
insurance. The welfare gains from the expansion of insurance are modest. They represent
3.3% of annual consumption expenditures in the 2005 environment.
Hence, both the growth of insurance and income independently cannot explain the rise
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in health spending and longevity. Technological change has much larger effects. Allowing for
productivity growth in the 1965 environment increases health spending from $569 to $1,972,
a 247% increase. The increase in longevity is large, at 9.6 years. Welfare gains, as a result
of technology represent close to two thirds of annual consumption in the 2005 environment.
We can compare this result to the value of life. Aldy and Viscusi (2004) suggest that $200k
is a reasonable estimate for the value of a life year. This suggests that the additional 9.6
years are worth roughly $1.9m. Lifetime consumption (without discounting) is $2.8m in
the 2005 environment. Thus $1.9m represent roughly two thirds of life-time utility. Hence,
technological change accounts for a large share of the overall welfare gains over the period
1965 to 2005 and our estimates are consistent with a value of a life year close to $200k.
The negative mortality effect of other factors on longevity in 1965 is large (5 years).
However, the relevant effect to consider is the comparison between the technology scenario
and the 2005 scenario which imposes the trend in these other factors. Longevity is 1.3 years
lower in the “other factors” scenario, compared to the technology scenario. This is close
to the estimate of Preston, Glei and Wilmoth (2011) who report that male life expectancy
would be 0.9 years higher without the trend in smoking.
In Table 4, we compute the contribution of each factor to the change in medical spending
and life expectancy over the period 1965-2005. Income and insurance together account for
less than 12% of the overall increase in medical expenditures. Technology accounts for 30%,
while the deterioration of health - probably due to smoking and obesity - accounts for less
than 1%. This leaves 57.3% for complementarity effects since by construction allowing for all
factors yields 2005 spending level. In other words, the estimates suggest that the observed
growth in health care spending would not have occured if these factors had not changed
together. A similar story emerges with life expectancy, where most of the observed increase
appears to be due to technological change. Other health trends (obesity and smoking) have
considerably slowed down the growth of longevity. Interaction effects account for one third
of the observed increase in life expectancy.
Overall, the welfare gains from higher health care spending appear substantial. The
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estimates suggest that the benefits in terms of better health and longevity far outweigh the
costs in terms of higher health spending.
5.3 Insurance Coverage and Intertemporal Substitution Effects
In recent years, proposals to reform health insurance in the U.S. have focused on expanding
coverage prior to age 65 and on reforming Medicare to make it sustainable in the future.
Expansion of coverage may increase health care spending, health and perhaps even reduce
Medicare spending, if uninsured workers currently delay treatment until after they become
eligible for Medicare. Our model is well-suited to study such effects as it allows for a response
to changes in the price of investing in health along various margins: health care spending,
retirement and saving. To gauge the potential for intertemporal substitution, we construct
a scenario where we give uninsured workers access to the same insurance plan that workers
have. This effectively also provides retiree health coverage to those with tied coverage in
the model. We then simulate average health care spending and health status prior to and
after Medicare eligibility in that scenario, and compare them to the baseline.
The results, in Table 5, show that medical spending prior to age 65 increases for those
without insurance coverage in the baseline (Uninsured). But there is no significant decrease
in health spending post age 65 for this group. There is some evidence of intertemporal
substitution for those with employer-tied coverage (Tied), but the effects are small. As
expected, the fraction working decreases substantially prior to Medicare eligibility for those
with tied coverage who do not have a reason to delay retirement anymore (Madrian, 1994).
Between ages 60 to 64 the fraction that works decreases from 91% to 86% among those with
tied coverage in the baseline. There is evidence of improved health for the uninsured, as
the fraction in “very good or excellent health” increases from 80.4% to 87.9% between the
ages of 60 and 64. Furthermore, their labor supply increases slightly. However, little of that
health gain remains beyond age 65 and health spending is only slightly lower after age 65 for
this group. Hence, this simulation suggests that it is unlikely that health spending at older
ages will reduce as a result of the provision of insurance coverage to the uninsured prior to
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age 65. The changes occur at ages prior to age 65 but little change is observed afterwards.
6 Conclusion
In this paper, we present a life-cycle model of health care spending, savings and retirement
in an environment with uncertainty regarding health, earnings and mortality. The model
is built on the idea that health is a stock that agents invest in because it provides utility
benefits (e.g. it increases the amount of leisure available each year) and because it prolongs
life. The model parameters are estimated on data for a representative cohort that lives
through a period of rapid health care spending growth. Estimates of preference parameters
such as risk aversion and time preference are consistent with existing evidence from savings
and retirement models. Other parameter estimates yield very sensible estimates of price
and income elasticities of health spending and value of a life year estimates consistent with
evidence from the literature. The estimated model enables counterfactual exercises to re-
construct the changes experienced over the period 1965 to 2005 and to analyze the effect of
potential reforms.
We first considered a set of scenarios aimed at computing the contribution of various
factors to growth in health care spending and longevity. We implemented a calibration
procedure to estimate the changes in technology and other factors affecting mortality which
could rationalize the observed growth. We found, in the parameterization of the health-
production function, that improvements in productivity of 1.3% per year, along with an
independent deterioration of mortality rates from smoking and obesity at a rate of 0.9% per
year, could rationalize the growth observed in income and health insurance generosity over
the period.
Starting from 1965, we estimated that each factor independently could not explain the
observed growth in health care spending. But, when introduced simultaneously, their mu-
tual reinforcement led to rapid growth in health spending. Put simply, growth in income
and insurance is not worth much without access to a productive health-production technol-
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ogy. According to our estimates, complementarity effects accounted for more than half of
the increase observed in medical expenditures over the period. On the longevity side, the
estimates suggest that technological progress is the main driver of growth over the period.
Together they have produced important welfare benefits that may be worth as much as 76%
of 2005 consumption expenditures. As for health-care spending, complementarity effects are
also important for explaining the growth in longevity, with an estimated one third coming
from that source.
The presence of complementarity effects is perhaps important to understand how rela-
tively small differences in income and insurance growth across countries may lead to large
aggregate differences in health-spending growth when technological progress is growing at
the same pace across countries. Complementarity may strenghten these differences. The
U.S. has had both a larger income growth and expansion of health insurance coverage than
other developed countries after the Second World War. Even if technological progress has
occurred at the same pace across countries, complementarity effects may explain why U.S.
health spending growth has outpaced that of other countries, despite health spending being
relatively inelastic to income and insurance. If one does not account for complementarities
it is difficult to reconcile the observed growth with low income and co-pay elasticities. Fur-
thermore, there is much insight to be gained from analyzing within a structural framework
whether the growth in medical spending observed over the recent period was “worth it”. Our
estimates suggest that the rise of health care spending increased welfare by a great deal,
with the largest contribution coming from technological progress.
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Appendix A Institutional Details
Taxes
Taxes are the sum of federal tax, τf (y), the employee portion of the Social Security earnings
tax and the Medicare tax. The federal tax is modeled using the following formula from
Gouveia and Strauss (2000):
τf (y) = a0[y − (y−a1 + a2)−1/a1 ],
where y is the sum of all income sources. We use the 1989 parameters, a0 = 0.258,
a1 = 0.768 and a2 = 0.031. The Social Security earnings tax is 6.2% up to a maximum of
$97,500 in earnings. The Medicare tax is 1.5% of earnings and there is no maximum.
Social Security
The formula for updating the average indexed monthly earnings (AME) prior to age 60 is
given by
amet+1 = amet +min(y
e
t , ssmax)/(35× 12)
where ssmax = 97, 500. After age 60, the formula is given by
amet+1 = amet + (min(y
e
t , ssmax)− χtamet)/(35× 12)
where χt is the probability that the AME will not be updated (French, 2005). This proba-
bility is computed by simulating earnings histories from the earnings process in the model
and counting the frequency of updating using the true ame formula (i.e. the highest 35
years of earnings). This probability is 9.1% at age 60, and it reaches 59% by age 69.
The primary benefit is a piece-wise linear function of amet. The bendpoints for someone
born in 1940 are $477 and $2,875: each dollar counts for 0.9 below the first bendpoint, for
0.32 in the second segment, and for 0.15 above the second bendpoint.
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The full retirement age (FRA) for someone born in 1940 is 65 and 6 months which we
round as 65. If the agent claims prior to the FRA, he is penalized with a 6.7% reduction per
year. Someone claiming at age 62 will receive 82% of his primary insurance amount (PIA).
But if the agent claims after the FRA, he is granted a delayed retirement credit which for
someone born in 1940 is 7% per additional year, compounded. Hence, someone claiming at
age 70 will receive 40% more. We denote this age adjustment ζ(t). The actuarially fair rate
will vary across agents depending on their survival prospects.
At the time of claiming benefits, we adjust the amet+1 such that
amet+1 = PIA
−1(ζ(t)PIA(amet))
This will permanently set amet+1 to a value such that PIA(amet+1) = ζ(t)PIA(amet).
Hence, we do not need to keep track of the age when someone claimed, t, in the state space.
The agent is allowed to work while collecting benefits. But he will suffer a benefit
reduction if his earnings are above a limit, which we set at $10,000 for this cohort. The
penalty will depend on age. Prior to the FRA, the penalty is 50%. Hence, each dollar above
the earnings limit cuts back current benefits by 50 cents. After the FRA, the penalty is
33%.
Government Transfers
The resource floor is set at $10,000. This figure is derived from the Office of the Assis-
tant Secretary for Planning and Evaluation (ASPE, 2008), which states that the maximum
monthly benefit payable to a couple with one child under the Temporary Assistance for
Needy Families (TANF) program was $495 in 2006. That year, the average monthly benefit
of recipients on food stamps (for a 3-person agent) was $283. Hence, prior to age 65, the sum
of TANF and food stamp benefits totaled $778/month for a 3-person agent, or $9,336/year
(ignoring the lifetime TANF receipt limit). The Social Security Administration reports that
the 2004 maximum monthly federal payment for SSI was $552 for a single and $829 for
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couples; including food stamps yields an annual total of $7,620 for singles and $12,180 for
couples.
If resources are below the resource floor, the agent is eligible for Medicaid if he does
not have coverage through an employer or Medicare. As we detail below, we allow the co-
insurance rate to be lower for such agents. When simulating agents using the income profiles
described above, there are three periods over the life-cycle when agents are likely to receive
transfers. First, this may happen at the beginning of the life-cycle when agents have saved
little and may suffer from a large earnings shock. Fewer than 2% of agents with a head aged
35 years old or less receive transfers. The second period is between the ages of 50 and 62.
There, some agents will leave the labor force and live on other income. This occurs mostly
for agents with poor health and few resources. Between these ages, an average of 7% of
agents receive transfers in the baseline simulations. The last age span where agents receive
transfers is at the end of life. After age 85, some agents who receive little in the form of
Social Security benefits see their other income decline (due for example to the death of a
spouse). They spend down their wealth and eventually receive government transfers. Fewer
than 5% of agents with a head age 85 or older receive such transfers.
Health Insurance
We use MEPS data to calibrate the co-insurance rate function ψ(). We use MEPS reports
of out-of-pocket and total medical expenditures. In the model, we use estimates of the
median co-insurance rate for each insurance plan. Insurance takes three value in MEPS
public data: not insured, government insurance and private health insurance. We assume
all respondents age 65+ with government insurance are on Medicare and that prior to age
65 those with government insurance are on Medicaid. We use medians because they are less
affected by outliers. This yields a co-insurance rate of 1 for those without health insurance,
0.07 for those on Medicaid, 0.25 for those with employer plans and 0.2 for those age 65+ (on
Medicare). The distribution of these co-insurance rates by insurance plan is given below.
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Parameters 25th median 75th mean
No insurance 0.40 1 1 0.72
Medicaid 0.01 0.07 0.35 0.23
Private 0.11 0.25 0.48 0.33
Medicare 0.06 0.20 0.48 0.312
Appendix B Micro Data
Panel Study of Income Dynamics
We use the PSID version created by the Cornell Equivalent File Project (CNEF).12 These
files include consistent variables for the years 1980 to 2005. The PSID interviews are done
each year up to 1997 and every two years afterwards. We keep male agent heads and drop
respondents from the oversample of low-income agents. We keep ages 21 to 99. Some of the
analysis further restricts the sample. Sample weights are used whenever possible in order
to make the sample representative. We also use the wealth surveys of 1984, 1989, 1994,
1999, 2001, 2003 and 2005. This data is obtained directly from PSID. Finally, additional
information on labor force status, pension income and health insurance status is obtained
from the individual and family files from the PSID. A total of 71,375 observations are
available across all years with an average of approximately 3000 per year. A total of 7206
agent heads are followed over time with 16,5% of those followed for 22 waves. Below is
information on the variables used in the analysis.
Wealth
We use the variable SX17, which is the sum of values of seven asset types, net of debt value
plus home equity (X refers to wave). Values above $1e6 are recoded as missing. Wealth is
converted to 2005 dollars using the CPI.
12The files can be obtained at the CNEF homepage
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Earnings
We use the variable i11110 from the CNEF. Earnings set to missing if above $250,000 or
below $5,000 or if hours worked are too low or too high. We convert earnings to 2005 dollars
using the CPI.
Other Income
We set other income to the sum of spousal earnings plus the sum of agent private pension
and annuity income. We exclude values above $250,000. We convert to 2005 dollars using
the CPI.
Health
We use self-reported health from the CNEF. This variable is available from 1984 to 2005
on a scale going from 1 (excellent) to 5 (poor). We create three categories (poor-fair, good,
very good-excellent).
agent Composition
We use the number of members of the agent.
Education
Education is used as an instrument for estimating the equation for other income. It is
defined as a 0/1 variable equal to one if the respondent has a college degree.
Birth Year
Birth year is recoded in 6 groups: earlier than 1925, 1926-1934, 1935-1944, 1945-1954, 1955-
1964 and after 1966. The reference group in the various analysis we run is 1935-1944.
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Medical Expenditure Panel Study
We use data from years 2000 to 2004 from the Medical Expenditure Panel Study (MEPS).
We use data from the agent component full year consolidated data files. We select male
respondents age 25 to 85 for the analysis. The MEPS interviews respondents over a 2 year
span. Each panel, initially drawn from the National Health Interview Survey (NHIS) is
surveyed 5 times. One panel starts each year. A total of 75,462 person-year were collected
between 2000 and 2004.
Mortality
The MEPS indicator for mortality leads to an underestimate of mortality. But MEPS re-
spondents are drawn from the NHIS. The NHIS has linked records of respondents with
National Death Records for years 1985 to 2006. Hence, we link the MEPS record to the
mortality follow-up conducted in MEPS. We then define mortality as occuring if the respon-
dent died within the year following his interview. To validate the quality of mortality data,
we merge these records period with period life tables for males by year and age (obtained
from the Human Mortality Database) as well as cohort mortality rates for those born in
1940 from the Social Security Administration. The next figure shows the close correspon-
dence although the small sample size beyond age 75 yields very volatile mortality rates.
There is also some underestimation at older ages, probably due to the non-follow up of the
institutionalized population in MEPS. But overall, the aggregate one-year mortality rate in
the age range 25 to 85 is 0.012 in the MEPS-NHIS dataset while it is 0.013 according to
period life-table. There is little difference in cohort and period mortality rates until age 70.
Period mortality rates are larger than cohort mortality rates after this age.
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Total Medical Expenditures
We use MEPS for the total medical expenditures over the calendar year using the CPI in 2005
dollars. We make three adjustments to this variable. First, we scale it up to the level of per
capita personal health care spending from the National Health Expenditures (NHE) report
for the years 2000 to 2004. MEPS surveys the non-institutionalized population. Hence,
at older ages it is likely to underestimate medical expenditures. Cutler and Meara (2004)
computed the adjustment factor to correct for this bias in MEPS. As a result, medical
expenditures for the age 75+ group are bumped up by 8%. Finally we censor medical
expenditures at $50,000 to limit the influence of outliers.
Other Variables
agent income is taken from the agent component of the MEPS data files. Obesity is defined
as a body-mass index of more than 30. A variable indicating whether the respondent ever
smoked is also constructed and used as control.
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Appendix C Estimation of Auxiliary Processes
Earnings
We select PSID men aged 25 to 70 working full-time between 1994 and 1997 (2-year gap
between waves after 1997). We have 42,764 person-years. The specification for annual real
gross earnings of the agent head is given by
E[log yeit|pii0, t] = pii0 + pi1t+ pi2t2
where the earnings shocks for the individual i ηit = log yeit−E[log yeit|pii0, t] follows an AR(1)
process ηit = ρηit−1+ εit, εit ∼ N(0, σ2ε). We first estimate parameters pi1, pi2 by fixed effect
regression (within estimator). We set the constant term to the average of the fixed effect for
those born between 1935 and 1945. Earnings peak around the age of 49 years old. We then
use the residuals (including the fixed effects) to estimate the covariance parameters (ρ, σε)
by minimum distance. The covariance parameter estimates are ρ̂ = 0.973 and σ̂2ε = 0.008.
Hence, earnings shocks are quite persistent. The following figure reports the average earnings
profile along with the 95% confidence interval using the unconditional variance of ηit.
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Other Income
We select PSID respondents from all waves, age 25 and over. We define other income as
the sum of private pension income, spouse earnings and spouse Social Security benefits. We
define the income of the agent head, yhit, as his earnings plus his social security benefits. The
econometric model is
yoit = pi3 + pi4y
h
it + pi5t+ pi6t
2 + λc + εit
where λc denotes cohort dummies. We instrument income of the agent head yhit with edu-
cation (a dummy for a college educated head) as in French (2005). We use the predicted
profile of a agent head born between 1935 and 1945. The following table gives the parameter
estimates. The profile is hump-shaped and there is a moderate correlation between income
of the agent head and other income. Using actual income of the agent head in the PSID
panel, we also plot the distribution of predicted other income by age.
Parameters Estimates Std. Error
pi3 -26109** 1224.1
pi5 990.6** 51.6
pi6 -7.822** 0.497
pi4 0.306** 0.009
Obs. 65008
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Initial Distribution of State Variables
We select male agent heads aged 24 to 28 (to boost sample size). There are minor cohort
differences in initial real earnings, health and assets. We neglect those. The initial insurance
coverage state is missing in PSID. For that, we use RAND HRS respondents aged 50 to 55
and born between 1935 and 1945 to estimate the extent of employer-tied and retiree coverage.
We estimate that 20% of respondents do not have employer provided insurance, 40.1% have
employer-tied coverage and 39.9% have retiree coverage. We use those estimates to draw
initial health insurance coverage. By construction, there is no correlation between other
initial state variables and insurance state. The initial sample size is 2,500 respondents. We
duplicate each observation and then take a sample with replacement of size 5,000. Initial
earnings are used to initialize the error term η25. Since we do not have data on ame25, we
fix it to zero.
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Appendix D Estimation of Health Processes
We use MEPS to estimate health and mortality processes. We use data on males aged 25
to 85.
Health
Let hit+1 = j be the health status at age t + 1, j = 1, 2, 3 . Current health status is
hit = k, k = 1, 2, 3. We specify the following dynamic multinomial model with controls for
risk factors, xit (smoking and obesity status) where
Pr(hit+1 = j|hit = k, t,mit, xit) = e
δ0jk+δ1jt+δ2j logmit+δ3j logm
2
it+xitδ4j∑
j′ e
δ0j′k+δ1j′ t+δ2j′ logmit+δ3j′ logm2it+xitδ4j′
We normalize parameters of health state j = 1 to zero. One might be worried that mit is
endogeneous. The vector xit is included in the specification we estimate as control variables.
It includes an indicator for ever smoking and one for obesity (BMI>30), which alleviates
some of the concerns with respect to common factors (such as socio-economic status) affect-
ing both medical spending (and health. Current health state hit = k captures the history
of the health process assuming it is Markovian. This also helps alleviate concerns about
unobserved heterogeneity since we are comparing people with the same health status. How-
ever, there might be simultaneity if the current health shock increases medical spending.
This would bias downward the effect of health spending on health. In fact, direct estimation
reveals negative effects of medical spending on health.
We use a control function approach to correct for the simultaneity of mit (Peltrin and
Train, 2010). At time t, determinants of medical spending that are uncorrelated with the
health shock, conditional on hit and xit, are good candidates for instruments. Given the
model, the log of current agent income should be correlated with current medical spending
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but not with next year’s health status. Hence, we first run the following regression
logmit = ϕ1 +
∑
k>1
ϕkI(hit = k) + zitϕ6 + xitϕ7 + ϕ8t+ νit
where zit is the log of agent income. Results are presented in the next table. A partial
F-test on the instruments yields a value that indicates the instruments are not weak.
Parameters Estimate Robust Std. Err.
ϕ1 (constant) 1.542** 0.301
ϕ2 (good) -0.904** 0.137
ϕ3 (>good) -1.208** 0.130
ϕ6 (log income) 0.124** 0.024
ϕ7,1 (obese) 0.592** 0.098
ϕ7,2 (smoking) -0.152** 0.089
ϕ8 (age) 0.081** 0.002
N 4686
R-squared 0.183
Partial-F log income 26.67
We compute residuals ν̂it , which we plug into the health process that becomes
Pr(hit+1 = j|hit = k, t,mit, xit, ν̂it) = e
δ0jk+δ1jt+δ2j logmit+δ3j logm
2
it+xitδ4j+ν̂itδ5j∑
j′ e
δ0j′k+δ1j′ t+δ2j′ logmit+δ3j logm2it+xitδ4j′+ν̂itδ5j′
Standard errors are computed by bootstrap to account for the estimation noise from es-
timating νit. We report the results of estimation by maximum likelihood in the following
table. Health decreases with age; there is considerable state-dependence in health as revealed
by the current health effects, particularly in good health states. Obesity and smoking are
negatively correlated with health.
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Parameters Good >Good
Par Std.Err Par Std.Err
δ0 (constant: <good) -1.409 0.539 -3.054** 0.845
δ0 (good) 2.695** 0.221 3.609** 0.334
δ0 (>good) 3.219** 0.279 6.031** 0.421
δ1 (age) -0.053** 0.013 -0.109** 0.021
δ2 (logmit) 0.712** 0.164 1.332** 0.252
δ3 (logm2it) -0.027** 0.004 -0.045** 0.005
δ4,1 (obese) -0.452** 0.139 -0.852** 0.193
δ4,2 (smoking) -0.063 0.103 -0.111 0.126
δ5 (ν̂it) -0.568** 0.164 -1.074** 0.257
N 4621
The parameter estimates of δ5j are jointly significantly different from zero which reveals
that mit is endogeneous. The estimates reveal that health spending has a positive effect on
health, increasing the likelihood of good health states.
Mortality
Mortality depends on age and health status and follows a Gompertz hazard function. The
probability of death over a one-year interval is given by
Pr(dit+1 = 1|hit = k, t) = 1− exp(− exp(δ6t) exp(δ7,k))
Parameters are estimated by maximum likelihood. Parameter estimates are reported in
the next table.
Parameters Estimate Std. Error
δ7,1 (constant) -7.451** 0.543
δ7,2 (good) -1.259** 0.257
δ7,3 (>good) -1.765** 0.263
δ6 (age) 0.069** 0.007
N 7,392
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There are two issues with the estimated mortality process. First, MEPS data is lacking at
older ages. So we extrapolate from the process estimated at younger ages. Second, given the
limited number of years, it was not possible to include cohort effects. But the model requires
a cohort life-table for those born between 1935 and 1945. Hence, we use cohort mortality
rates from Social Security to construct a correction factor such that average mortality rates
computed from the health data are equal to the Social Security mortality rates.
Appendix E Solution Method and Estimation of Preference Pa-
rameters
Solution Method
Starting at the last age, which we set at T = 110, mortality is certain in the following period.
Therefore, the agent consumes all resources left at that point. This means we know VT (sT ).
Proceeding recursively, we discretize the continuous variables of the state-space with more
points at lower values (assets and average indexed monthly earnings). We use 48 asset points
and 24 AME points. To solve for optimal consumption and medical expenditures, we also use
grid search with 24 points for each variable. We use bi-linear intrapolation for next period’s
value function. For integration of earnings shocks, we follow the discrete approximation
approach of Tauchen (1986) and use 9 points. Once we have solved for optimal decision
rules, we simulate the life paths of 5,000 agents using draws of earnings, health, mortality
and initial conditions from the data (described in the next section).
Construction of Moment Conditions
There are four sets of moment conditions. Each compares a statistic computed from the
data to one computed from simulations. We first describe how we compute the statistics
from the data.
First, we seek to construct a mean wealth profile by age from the PSID which is not
contaminated by cohort effect and agent composition. We follow French (2005) and estimate
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a fixed effect regression with controls for agent size and an unrestricted set of age dummies.
We then construct the profile by using the average of the fixed effects for those born between
1935 and 1945 and a agent size of 3.
Next, the average medical expenditures by age are computed from MEPS. Because of
smaller sample size than for wealth, we opt for a regression which directly controls for
birth year, agent size and unrestricted age dummies. We then predict average medical
expenditures for someone born between 1935 and 1945 with a agent size of 3.
Labor force participation by age is predicted separately for those in poor-fair health and
those with good and very good-excellent health. We use regressions which control for cohort
effects and unrestricted age dummies. When predicting we set the cohort effects for someone
born between 1935 and 1945.
Finally, we seek to match mortality rates for this cohort. We know from lifetables that
there are significant cohort effects in mortality. We use cohort mortality rates for those born
in 1940 from the Social Security Administration. This profile was also used to correct the
mortality process described in Appendix D and was shown in Appendix B.
We compute standard errors for each moment by computing the deviation of (adjusted)
respondent level data to the statistics computed above. We use the strategy outlined in
French (2005) to deal with the unbalanced nature of the PSID and MEPS panels.
Estimator
Denote the jth moment condition involving the variable z by
g˜j(θ) =
1
N
∑
i∈nj
(
zi,j(θ0)− 1
S
∑
s
z˜s,j(θ)
)
where N denotes the combined sample size of PSID and MEPS used in estimating the mo-
ment vector, zi,j(θ0) the adjusted data of respondent i contributing to the moment condition
(there are nj such respondents) , and finally z˜s,j(θ) simulated data from draw s of shocks
(earnings and health). S denotes the number of simulations. The data is by assumption
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generated from the model at the true value of the parameters θ0. Stacking these moment
conditions, we obtain a vector g˜N (θ) which has expectation zero at θ = θ0. The Method of
Simulated Moment (MSM) estimator is given by
θ̂MSM = argmin
θ
N
1 + τ
g˜N (θ)
′WN g˜N (θ)
where WN is the inverse of the covariance matrix of the data and τ = N/S. Given some
regularity conditions, the MSM estimator is consistient for θ0 for fixed S when N goes to
infinity. It is also asymptotically normal. An estimate of the variance matrix of the estimates
is given by
V (θMSM ) = (1 + τ)
(
G′NWNGN
)−1
where GN is the matrix of derivatives of the moment vector with respect to the parameters.
If the model is correctly specified the value of the objective function is distributed as a χ2
random variable with J −K degrees of freedom where J denotes the number of moments
and K denotes the number of parameters to be estimated.
Since the objective function is generally not smooth and has local minima, we use the
Nelder-Mead algorithm to find the minimum.
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Figure 1: Mortality Rates by Current Health Status and Level of Medical Expen-
ditures, Age 65+: Effects are obtained by combining the marginal effects from the health
process weighted by the conditional mortality probabilities by health status and averaged
over the population age 65+.
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Figure 2: Age Profiles from Data and Simulations: The solid lines show the average
profile from the data; 95% confidence intervals of the data are shown by dotted lines. The
dashed lines show the simulated profiles. In the top right panel, the fraction working by age
is shown for those in very good or excellent health (higher profile) and in poor or fair health
(lower profile).
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Tables
Parameter Point Estimate Std. Error
σ 3.365 0.958
γ 0.436 0.005
φ1 696.1 708.3
φ2 371.6 442.3
β 0.983 0.036
α2 0.190 0.149
α3 0.219 0.047
S 5,000
N 10,848
#moments 50
OIV (df=43) 164.8
Table 1: Preference Parameter Estimates by Method of Simulated Moments:
Standard errors computed at the solution using the formula shown in Appendix E. S refers
to the number of simulated individuals while N is the number of different respondents used
in estimating the profiles from the data. The overidentifcation test value is given by the
value of the objective function of the MSM estimator at the minimum and is distributed
as a chi-square with 43 degrees of freedom.
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Parameter No Controls Controls Fixed Effects
log(Income) 0.592** 0.538** 0.513**
(0.002) (0.004) (0.003)
log(co-insurance) -0.555** -0.570**
(0.002) (0.001)
Obs 122,778 117,778 117,778
R-squared 0.835 0.957 0.934
Table 2: Income and Co-insurance Elasticities of Health Care Spending in Base-
line Simulations: Standard errors are calculated using clustering at the respondent level.
The first specification includes age dummies (5-year intervals). The second adds health sta-
tus and assets. The last specification uses the within fixed effect estimator. Prior to age 50,
insurance status does not vary within respondent. Hence, co-insurance is excluded from the
fixed effect specification. ** denotes p<0.05.
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Outcome 1965 Income Insurance Technology Other 2005
Avg. total medical exp. 569.1 771.7 929.2 1972.5 593.1 5257.2
Avg. oop exp. 386.4 519.9 303.9 933.2 404.6 1330.3
life expectancy 69.8 70.3 70.1 79.4 64.9 78.1
CV 1965 (%) - 26.7% 3.3% 64.3% 75.5%
Table 3: Simulation Scenario Results 1965-2005: Results in the first column pertain
to the 1965 environment. The second column implements the 2005 income scenario keep-
ing insurance and technology at their 1965 level. The third column implements the 2005
insurance scenario keeping 1965 income and technology. The fourth column implements the
2005 technology scenario keeping income and insurance at their 1965 level. The fifth column
implements the increase in mortality due to other factors (notably smoking and obesity).
Finally, the last column reports results for the baseline scenario in 2005. The last line com-
putes the fraction of consumption in each scenario which would need to be taken away from
consumers such that they enjoy the same welfare at age 25 as in the 1965 environment. It
is a measure of compensating variation (CV).
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Outcome (% total) Income Insurance Technology Other Complementarity
Medical spending 4.3 7.7 29.9 0.5 57.3
Life expectancy 6.0 3.6 115.7 -59.0 33.7
Table 4: Contribution to Growth in Medical Spending and Longevity 1965-2005:
The first column implements the 2005 income scenario keeping insurance and technology
at their 1965 level. The second column implements the 2005 insurance scenario keeping
1965 income and technology. The third column implements the 2005 technology scenario
keeping income and insurance at their 1965 level. The fourth column implements other
changes to mortality during the period (notably obesity and smoking), keeping everything
else unchanged. The last column reports the residual growth which can be interpreted as a
complementarity effect between scenarios.
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Baseline Expansion
health spending
age Uninsured Tied Uninsured Tied
60-64 $ 3,293.7 $ 6,973.4 $ 6,892.5 $ 6,802.8
65-75 $ 10,130.3 $ 10,532.4 $ 10,108.8 $ 9,976.8
health excellent
age Uninsured Tied Uninsured Tied
60-64 0.804 0.874 0.879 0.884
65-75 0.786 0.791 0.803 0.793
working
age Uninsured Tied Uninsured Tied
60-64 0.834 0.910 0.862 0.859
65-69 0.284 0.283 0.288 0.278
Table 5: Expansion of Insurance prior to Medicare Eligibility: Simulated outcomes
in the baseline, and in the insurance expansion scenario which provides the uninsured with
the same plan as that of workers with employer provided health insurance.
56
